Viveca Gyberg

About me
Publications
CV
Public outreach and news

About me

Viveca Gyberg finished her medical degree at Karolinska Institutet in 2009, including exchangestudies at Mount Sinai School of Medicine, New York, USA. Immediately after graduating, she started her medical internship (AT) at Karolinska University Hospital in Solna, after which she in 2011 began her five-year resident program to become a specialized family physician. She was soon awarded the position as a research resident adding two years of funded research to her specialist training which enabled her to defend her thesis on prevention of cardiovascular disease and diabetes in 2014 with Professor Lars Rydén as main supervisor. In addition to her medical education she had spent one year (2005-2006) studying Management and International Relations at the University of St. Andrews in Scotland and six months (2002) studying democracy and human rights at the Teologiska Högskolan in Stockholm. Viveca Gyberg has since February 2015 worked as a reoccurring TV-doctor in TV4s program Vardagspuls. She is an appreciated teacher, advisor and lecturer.

Research

Viveca Gyberg has a strong passion for public health and prevention both on individual and societal level. After defending her thesis in 2014 on prevention of cardiovascular disease and diabetes, Viveca Gyberg has continued as a postdoc studying prevention strategies of cardiovascular disease and diabetes in different risk groups as well as the general population. Her area of research covers policy, lifestyle, drugs, risk markers, diagnostics and medical interventions.

Articles

Article: ATHEROSCLEROSIS. 2019;285:135-146

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

De Backer G; Jankowski P; Kotseva K; Mirrakhimov E; Reiner Ž; Rydén L; Tokgözoğlu L; Wood D; De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres, organisations, investigators and ot
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2019;34(3):247-258

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.

De Bacquer D; De Smedt D; Kotseva K; Jennings C; Wood D; Rydén L; Gyberg V; Shahim B; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Wagner M; De Backer G; EUROASPIRE Investigators
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2019;16(1):22-27

Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.

Smáradóttir MI; Catrina S-B; Brismar K; Norhammar A; Gyberg V; Mellbin LG
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2018;25(18):1990-1999

Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje.

Shahim B; Hasselberg S; Boldt-Christmas O; Gyberg V; Mellbin L; Rydén L
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;272:20-25

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.

De Smedt D; Annemans L; De Backer G; Kotseva K; Rydèn L; Wood D; Amouyel P; Bruthans J; Cifkova R; De Sutter J; Dolzhenko M; Erglis A; Gotcheva N; Gyberg V; Laucevicius A; Lovic D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Stagmo M; De Bacquer D
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2018;15(6):511-518

Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction.

Wang A; Arver S; Flanagan J; Gyberg V; Näsman P; Ritsinger V; Mellbin LG
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2018;20(9):596-602

The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease.

Shahim B; Kjellström B; Gyberg V; Jennings C; Smetana S; Rydén L
Article: CARDIOVASCULAR DIABETOLOGY. 2018;17(1):21

Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.

Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
Article: GLOBAL HEART. 2017;12(4):315-322.e3

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.

Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D; EUROASPIRE Investigators
Article: DIABETES CARE. 2017;40(9):1233-1240

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology.

Shahim B; De Bacquer D; De Backer G; Gyberg V; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2017;14(2):69-76

Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.

Smaradottir MI; Ritsinger V; Gyberg V; Norhammar A; Näsman P; Mellbin LG
Article: BMJ OPEN. 2016;6(12):e013835

Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.

Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2016;23(18):2007-2018

Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.

Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2016;23(6):636-648

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.

Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; EUROASPIRE Investigators
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2015;17(10):755-758

Accuracy of a Simplified Glucose Measurement Device--The HemoCue Glucose 201RT.

Segerhag E; Gyberg V; Ioannides K; Jennings C; Rydén L; Stagmo M; Hage C
Article: CARDIOVASCULAR DIABETOLOGY. 2015;14:133

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.

Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; EUROASPIRE Investigators
Article: LAKARTIDNINGEN. 2015;112:DLH9

[Glucose impairment despite normal HbA1c or fasting plasma glucose].

Gyberg V
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2015;22(6):753-761

Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.

Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD; EUROASPIRE Study Group
Article: EUROPEAN HEART JOURNAL. 2015;36(19):1171-1177

Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.

Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L; EUROASPIRE IV Investigators
Article: PRIMARY CARE DIABETES. 2012;6(2):103-107

Measuring risk online--feasibility of using FINDRISC in an online workplace survey.

Gyberg V; Hasson D; Tuomilehto J; Rydén L
Article: JOURNAL OF CARDIOVASCULAR RISK. 2011;18(5):745-753

Policymakers' perceptions of cardiovascular health in Europe.

Gyberg V; Rydén L
Show more

All other publications

Letter: LANCET DIABETES & ENDOCRINOLOGY. 2016;4(9):732-733

Oral glucose tolerance testing and cardiovascular disease.

Rydén L; Gyberg V; Schnell O; Tuomilehto J; EUROASPIRE IV investigators
Letter: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2015;66(14):1634-1636

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients.

Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D; EUROASPIRE Investigators
KI thesis / dissertation: 2014

Prevention of cardiovascular disease and diabetes on a population level

Gyberg, Viveca

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2014
University Medical Degree, Karolinska Institutet, 2009

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI